A phase III study (EMBRACE) of eribulin mesylate versus treatment of physician's choice in patients with locally recurrent or metastatic breast cancer previously treated with an anthracycline and a taxane. - Twelves,C.; Loesch,D.; Blum,J.L. (J Clin Oncol, 2010)